Marion R. Zillhardt, Ph.D.
Affiliations: | 2011 | Cancer Biology | University of Chicago, Chicago, IL |
Area:
Cell Biology, OncologyGoogle:
"Marion Zillhardt"Parents
Sign in to add mentor| Ernst Lengyel | grad student | 2011 | Chicago | |
| (Stromal-mediated activation of c-MET in ovarian cancer metastasis: Opportunities for therapy.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Mitra AK, Zillhardt M, Hua Y, et al. (2012) MicroRNAs reprogram normal fibroblasts into cancer-associated fibroblasts in ovarian cancer. Cancer Discovery. 2: 1100-8 |
| Boyerinas B, Park SM, Murmann AE, et al. (2012) Let-7 modulates acquired resistance of ovarian cancer to Taxanes via IMP-1-mediated stabilization of multidrug resistance 1. International Journal of Cancer. 130: 1787-97 |
| Zillhardt M, Lengyel E. (2012) Abstract 48: Activation of c-Met receptor signaling by carcinoma-associated fibroblasts in the tumor microenvironment Cancer Research. 72: 48-48 |
| Mitra AK, Zillhardt M, Hua Y, et al. (2012) Abstract 1481: microRNA mediated reprograming of fibroblasts into cancer associated fibroblasts in ovarian cancer Cancer Research. 72: 1481-1481 |
| Nieman KM, Kenny HA, Penicka CV, et al. (2011) Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nature Medicine. 17: 1498-503 |
| Zillhardt M, Park SM, Romero IL, et al. (2011) Foretinib (GSK1363089), an orally available multikinase inhibitor of c-Met and VEGFR-2, blocks proliferation, induces anoikis, and impairs ovarian cancer metastasis. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 4042-51 |
| Zillhardt M, Christensen JG, Lengyel E. (2010) An orally available small-molecule inhibitor of c-Met, PF-2341066, reduces tumor burden and metastasis in a preclinical model of ovarian cancer metastasis. Neoplasia (New York, N.Y.). 12: 1-10 |
| Kaur S, Kenny HA, Jagadeeswaran S, et al. (2009) {beta}3-integrin expression on tumor cells inhibits tumor progression, reduces metastasis, and is associated with a favorable prognosis in patients with ovarian cancer. The American Journal of Pathology. 175: 2184-96 |
| Kenny HA, Dogan S, Zillhardt M, et al. (2009) Organotypic models of metastasis: A three-dimensional culture mimicking the human peritoneum and omentum for the study of the early steps of ovarian cancer metastasis. Cancer Treatment and Research. 149: 335-51 |
| Schiller KR, Zillhardt MR, Alley J, et al. (2009) Secretion of MCP-1 and other paracrine factors in a novel tumor-bone coculture model. Bmc Cancer. 9: 45 |